TMEM16A/ANO1 suppression improves response to antibody-mediated targeted therapy of EGFR and HER2/ERBB2.
Genes, Chromosomes & Cancer
Kulkarni, Sucheta S; Bill, Anke A; Godse, Neal R NR; Khan, Nayel I NI; Kass, Jason I JI; Steehler, Kevin K; Kemp, Carolyn C; Davis, Kara K; Bertrand, Carol A CA; Vyas, Avani R AR; Holt, Douglas E DE; Grandis, Jennifer R JR; Gaither, L Alex LA; Duvvuri, Umamaheswar U